Choroid Plexus Epithelial Cells

Choroid Plexus Epithelial Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Choroid Plexus Epithelial Cells</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Choroid plexus (lateral, third, fourth ventricles)</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>TTR (transthyretin), AQP1 (aquaporin 1), KCNQ1, SLC12A2 (NKCC1)</td>
</tr>
<tr>
<td class="label">Developmental Origin</td>
<td>Neuroectoderm, roof plate</td>
</tr>
<tr>
<td class="label">Key Functions</td>
<td>CSF production, BCSFB, molecular filtration</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000706](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000706](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4301608](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4301608)</td>
</tr>
</table>

Choroid Plexus Epithelial Cells

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Choroid Plexus Epithelial Cells</th>
</tr>
<tr>
<td class="label">Location</td>
<td>Choroid plexus (lateral, third, fourth ventricles)</td>
</tr>
<tr>
<td class="label">Marker Genes</td>
<td>TTR (transthyretin), AQP1 (aquaporin 1), KCNQ1, SLC12A2 (NKCC1)</td>
</tr>
<tr>
<td class="label">Developmental Origin</td>
<td>Neuroectoderm, roof plate</td>
</tr>
<tr>
<td class="label">Key Functions</td>
<td>CSF production, BCSFB, molecular filtration</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000706](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)</td>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:0000706](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4301608](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4301608)</td>
</tr>
</table>

Choroid plexus epithelial cells (CPECs) are specialized ependymal cells that form the blood-cerebrospinal fluid barrier (BCSFB) and produce cerebrospinal fluid. They represent a critical interface between the peripheral circulation and the central nervous system, playing increasingly recognized roles in neurodegenerative disease pathogenesis. [@schwarzman2004]

Overview

Multi-Taxonomy Classification

Taxonomy Database Cross-References

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000706)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)
• [OBO Foundry (CL:0000706)](http://purl.obolibrary.org/obo/CL_0000706)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)
• [PanglaoDB](https://panglaodb.se/)

Taxonomy & Classification

PanglaoDB Marker Cross-References

• Unknown (PanglaoDB):

External Database Links

• [Cell Ontology (CL:0000706)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000706)
• [OBO Foundry (CL:0000706)](http://purl.obolibrary.org/obo/CL_0000706)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [PanglaoDB](https://panglaodb.se/)

Anatomy

The choroid plexus consists of:

• Epithelial cells: Cuboidal cells with microvilli and cilia
• Capillary endothelium: Fenestrated capillaries
• Stromal tissue: Connective tissue core

BCSFB Structure

Unlike the BBB, the BCSFB has:

• Tight junctions between epithelial cells
• Fenestrated capillaries (leaky)
• Epithelial barrier is the main constraint
• High mitochondrial density for active transport

Normal Physiological Functions

CSF Production

CPECs produce CSF via:

• Active transport: Ion pumps (Na+/K+ ATPase, NKCC1)
• Aquaporin 1: Water transport
• Secretory vesicles: Protein and peptide secretion
• Daily production: ~500 mL/day in adults

Barrier Function

• Tight junctions restrict paracellular flow
• Selective transporters allow essential molecules
• Efflux pumps remove waste products
• Drug permeability differs from BBB

Molecular Transport

CPECs express:

• Transthyretin (TTR): T4 transport
• Transferrin receptor: Iron transport
• Organic anion transporters: Drug clearance
• Various channels: Ion homeostasis

Role in Neurodegeneration

Alzheimer's Disease

The choroid plexus undergoes significant alterations in AD:

TTR Dysregulation: Transthyretin, normally produced by CPECs, has been shown to have protective effects against amyloid-beta aggregation. In AD, TTR expression is reduced, diminishing this neuroprotective function [1](https://pubmed.ncbi.nlm.nih.gov/12676788/).

CSF Production Decline: Age-related and AD-associated reductions in CSF production correlate with impaired clearance of metabolic waste products, including amyloid-beta and tau. Studies show CSF production decreases approximately 0.3% per year after age 50, with accelerated decline in AD patients [2](https://doi.org/10.1212/WNL.0000000000002495).

Barrier Breakdown: The BCSFB becomes "leakier" in AD, with disrupted tight junctions allowing peripheral proteins and potential neurotoxins into the CSF compartment. This compromise is associated with increased neuroinflammation [3](https://pubmed.ncbi.nlm.nih.gov/25672610/).

Iron Dyshomeostasis: CPEC iron transport dysfunction contributes to brain iron accumulation observed in AD. The transferrin receptor-mediated iron import becomes dysregulated, leading to oxidative stress [4](https://doi.org/10.1007/s12017-019-08569-z).

Parkinson's Disease

CPEC involvement in PD includes:

α-Synuclein Clearance: The choroid plexus can export α-synuclein through organic anion transporters. Impaired CPEC function may reduce clearance of toxic α-synuclein species from the CSF [5](https://pubmed.ncbi.nlm.nih.gov/28750445/).

Neuroinflammation: CPECs respond to systemic inflammation by producing cytokines that can propagate neuroinflammatory processes relevant to PD pathogenesis. The BCSFB serves as a conduit for peripheral immune signals [6](https://doi.org/10.1016/j.jneuroim.2019.02.016).

Drug Delivery: Reduced CPEC transporter function may limit delivery of therapeutic agents to the CNS in PD patients, contributing to treatment challenges [7](https://pubmed.ncbi.nlm.nih.gov/23528656/).

Amyotrophic Lateral Sclerosis

CSF Secretion Abnormalities: CPEC dysfunction may contribute to altered CSF composition in ALS, affecting motor neuron microenvironment. Studies show changes in CSF protein profiles correlate with disease progression [8](https://doi.org/10.1016/j.neurobiolaging.2018.02.025).

Barrier Permeability: Increased BCSFB permeability has been documented in ALS, potentially allowing toxic substances access to the CNS [9](https://pubmed.ncbi.nlm.nih.gov/26640156/).

Multiple System Atrophy

CPECs show:

• Altered tight junction expression
• Reduced CSF production capacity
• Impaired clearance of oligodendroglial proteins (α-synuclein)

Therapeutic Implications

Drug Delivery Targets

CPEC transporters can be leveraged for CNS drug delivery:

• Prodrug approaches: Utilize organic anion transporters to deliver L-DOPA precursors
• Nanoparticle delivery: Engineer particles that cross BCSFB via receptor-mediated transcytosis
• TTR enhancers: Develop compounds that upregulate transthyretin production

Regenerative Approaches

• Stem cell therapy: CPEC progenitors could restore barrier function
• Tight junction stabilizers: Protect BCSFB integrity
• Anti-inflammatory agents: Modulate CPEC-mediated neuroinflammation

Biomarker Potential

CPEC-derived markers may serve as disease biomarkers:

• TTR levels: Diagnostic and prognostic in AD
• AQP1 expression: Correlates with disease severity
• Barrier integrity markers: CSF/serum protein ratios

Research Directions

Emerging Areas

Challenges

• Technical difficulties in accessing choroid plexus tissue
• Limited understanding of CPEC aging
• Need for better in vitro models

Background

The study of Choroid Plexus Epithelial Cells has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [Allen Brain Atlas: Choroid Plexus](https://human.brain-map.org/static/atlas)choroid-plexus)
• [Human Protein Atlas: Choroid Plexus](https://www.proteinatlas.org/)choroid-plexus)
• [EMBROISE: Choroid Plexus Research](https://pubmed.ncbi.nlm.nih.gov/)

See Also

• [Alzheimer's Disease](/diseases/alzheimers)
• [Parkinson's Disease](/diseases/parkinsons)
• [Blood-CSF Barrier](/mechanisms/blood-cerebrospinal-fluid-barrier)
• [Cerebrospinal Fluid](/mechanisms/cerebrospinal-fluid-circulation)
• [Choroid Plexus](/brain-regions/choroid-plexus)
• [BBB Breakdown](/mechanisms/blood-brain-barrier-breakdown)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [Aging Brain](/mechanisms/aging-brain)
• [Epithelial Cells](/cell-types/epithelial-cells)
• [Tight Junctions](/mechanisms/tight-junctions)
• [CSF Biomarkers](/mechanisms/csf-biomarkers)